Clinical value of emergency interventional therapy for acute severe variceal upper gastrointestinal bleeding

Objective To evaluate the clinical value of emergency interventional therapy for patients with acute severe variceal upper gastrointestinal bleeding (ASVUGIB). Methods Clinical data of 48 ASVUGIB patients who received direct or remedial interventional therapy were collected retrospectively. They wer...

Full description

Bibliographic Details
Main Author: Chen Song, Shi Jianshan
Format: Article
Language:zho
Published: Editorial Office of Journal of New Medicine 2022-09-01
Series:Xin yixue
Subjects:
Online Access:https://www.xinyixue.cn/fileup/0253-9802/PDF/1664415629960-574692664.pdf
_version_ 1828127392842907648
author Chen Song, Shi Jianshan
author_facet Chen Song, Shi Jianshan
author_sort Chen Song, Shi Jianshan
collection DOAJ
description Objective To evaluate the clinical value of emergency interventional therapy for patients with acute severe variceal upper gastrointestinal bleeding (ASVUGIB). Methods Clinical data of 48 ASVUGIB patients who received direct or remedial interventional therapy were collected retrospectively. They were divided into the direct interventional therapy group (n = 40) and remedial interventional therapy group (n = 8). For patients with bleeding signs of contrast medium leakage in angiography, percutaneous transhepatic/transsplenic portal venography + variceal embolization + transjugular intrahepatic portosystemic shunt (TIPS) were performed; for patients without clear signs of bleeding, percutaneous transhepatic/transsplenic portal venography+variceal embolization were performed and TIPS was performed according to the pressure of the portal vein during the operation; for patients with portosystemic shunt, balloon-occluded retrograde transvenous obliteration (BRTO) and TIPS were performed. The patients were followed up for 6 months to observe the clinical prognosis. Results The diagnostic rate of vessels with bleeding lesions in the direct interventional therapy group was 78%, the effective rate was 78%; the rebleeding rates within 7 d, 30 d, 3 months and 6 months were 23%, 45%, 45% and 45%, respectively; the mortality rates within 7 d, 30 d, 3 months and 6 months were 15%, 28%, 28% and 28%, respectively. The diagnostic rate of vessels with bleeding lesions by angiography was 75% in the remedial interventional therapy group, the effective rate was 6/8; the rebleeding rates within 7 d, 30 d, 3 months and 6 months were 2/8, 4/8, 4/8 and 4/8, respectively; the mortality rates within 7 d, 30 d, 3 months and 6 months were 1/8, 3/8, 3/8 and 3/8, respectively. The liver functions (transaminase, albumin and bilirubin) and coagulation function of patients after interventional therapy were improved compared with those before treatment (all P < 0.05). Child-Pugh and MELD scores were decreased compared with those before treatment (both P < 0.05). Conclusions ASVUGIB is a common severe acute disease in clinical practice. Early diagnosis, intervention and treatment of ASVUGIB can significantly improve the prognosis of patients. Interventional therapy can be used as treatment for ASVUGIB patients who have contraindications or failures in gastroscopic therapy.
first_indexed 2024-04-11T15:49:04Z
format Article
id doaj.art-55fca524631e4ffcb63a763c256beecd
institution Directory Open Access Journal
issn 0253-9802
language zho
last_indexed 2024-04-11T15:49:04Z
publishDate 2022-09-01
publisher Editorial Office of Journal of New Medicine
record_format Article
series Xin yixue
spelling doaj.art-55fca524631e4ffcb63a763c256beecd2022-12-22T04:15:25ZzhoEditorial Office of Journal of New MedicineXin yixue0253-98022022-09-0153964364810.3969/j.issn.0253-9802.2022.09.005Clinical value of emergency interventional therapy for acute severe variceal upper gastrointestinal bleedingChen Song, Shi Jianshan0△ICU, the First Affiliated Hospital of Hainan Medical University, Haikou 570102, ChinaObjective To evaluate the clinical value of emergency interventional therapy for patients with acute severe variceal upper gastrointestinal bleeding (ASVUGIB). Methods Clinical data of 48 ASVUGIB patients who received direct or remedial interventional therapy were collected retrospectively. They were divided into the direct interventional therapy group (n = 40) and remedial interventional therapy group (n = 8). For patients with bleeding signs of contrast medium leakage in angiography, percutaneous transhepatic/transsplenic portal venography + variceal embolization + transjugular intrahepatic portosystemic shunt (TIPS) were performed; for patients without clear signs of bleeding, percutaneous transhepatic/transsplenic portal venography+variceal embolization were performed and TIPS was performed according to the pressure of the portal vein during the operation; for patients with portosystemic shunt, balloon-occluded retrograde transvenous obliteration (BRTO) and TIPS were performed. The patients were followed up for 6 months to observe the clinical prognosis. Results The diagnostic rate of vessels with bleeding lesions in the direct interventional therapy group was 78%, the effective rate was 78%; the rebleeding rates within 7 d, 30 d, 3 months and 6 months were 23%, 45%, 45% and 45%, respectively; the mortality rates within 7 d, 30 d, 3 months and 6 months were 15%, 28%, 28% and 28%, respectively. The diagnostic rate of vessels with bleeding lesions by angiography was 75% in the remedial interventional therapy group, the effective rate was 6/8; the rebleeding rates within 7 d, 30 d, 3 months and 6 months were 2/8, 4/8, 4/8 and 4/8, respectively; the mortality rates within 7 d, 30 d, 3 months and 6 months were 1/8, 3/8, 3/8 and 3/8, respectively. The liver functions (transaminase, albumin and bilirubin) and coagulation function of patients after interventional therapy were improved compared with those before treatment (all P < 0.05). Child-Pugh and MELD scores were decreased compared with those before treatment (both P < 0.05). Conclusions ASVUGIB is a common severe acute disease in clinical practice. Early diagnosis, intervention and treatment of ASVUGIB can significantly improve the prognosis of patients. Interventional therapy can be used as treatment for ASVUGIB patients who have contraindications or failures in gastroscopic therapy.https://www.xinyixue.cn/fileup/0253-9802/PDF/1664415629960-574692664.pdf|acute severe variceal upper gastrointestinal bleeding|emergency interventional therapy|portal hypertension
spellingShingle Chen Song, Shi Jianshan
Clinical value of emergency interventional therapy for acute severe variceal upper gastrointestinal bleeding
Xin yixue
|acute severe variceal upper gastrointestinal bleeding|emergency interventional therapy|portal hypertension
title Clinical value of emergency interventional therapy for acute severe variceal upper gastrointestinal bleeding
title_full Clinical value of emergency interventional therapy for acute severe variceal upper gastrointestinal bleeding
title_fullStr Clinical value of emergency interventional therapy for acute severe variceal upper gastrointestinal bleeding
title_full_unstemmed Clinical value of emergency interventional therapy for acute severe variceal upper gastrointestinal bleeding
title_short Clinical value of emergency interventional therapy for acute severe variceal upper gastrointestinal bleeding
title_sort clinical value of emergency interventional therapy for acute severe variceal upper gastrointestinal bleeding
topic |acute severe variceal upper gastrointestinal bleeding|emergency interventional therapy|portal hypertension
url https://www.xinyixue.cn/fileup/0253-9802/PDF/1664415629960-574692664.pdf
work_keys_str_mv AT chensongshijianshan clinicalvalueofemergencyinterventionaltherapyforacuteseverevaricealuppergastrointestinalbleeding